Pharmacokinetic similarity of biologics: analysis using nonlinear mixed-effects modeling.

Abstract : Our objective was to show, using two examples, that a pharmacokinetic (PK) similarity analysis can be performed using nonlinear mixed-effects models (NLMEM). We used two studies that compared different biosimilars: a three-way crossover trial with somatropin and a parallel-group trial with epoetin-α. For both data sets, the results of NLMEM-based analysis were compared with those of noncompartmental analysis (NCA). For the latter analysis, we performed an NLMEM-based equivalence Wald test on secondary parameters of the model: the area under the curve and the maximal concentration. Somatropin PK was described by a one-compartment model and epoetin-α PK by a two-compartment model with linear and Michaelis-Menten elimination. For both studies, similarity of PK was demonstrated by means of both NCA and NLMEM, and both methods led to similar results. Therefore, for establishing similarity, PK data can be analyzed by either of the methods. NCA is an easier approach because it does not require data modeling; however, NLMEM leads to a better understanding of the underlying biological system.
Type de document :
Article dans une revue
Clinical Pharmacology and Therapeutics, American Society for Clinical Pharmacology and Therapeutics, 2012, 91 (2), pp.234-42. 〈10.1038/clpt.2011.216〉
Liste complète des métadonnées

Littérature citée [30 références]  Voir  Masquer  Télécharger

http://www.hal.inserm.fr/inserm-00660524
Contributeur : Thu Thuy Nguyen <>
Soumis le : vendredi 22 juin 2012 - 14:48:57
Dernière modification le : mardi 11 octobre 2016 - 14:39:16
Document(s) archivé(s) le : dimanche 23 septembre 2012 - 02:20:09

Fichiers

DuboisetAl_cpt_2011.pdf
Fichiers produits par l'(les) auteur(s)

Identifiants

Collections

Citation

Anne Dubois, Sandro Gsteiger, S. Balser, Etienne Pigeolet, Jean-Louis Steimer, et al.. Pharmacokinetic similarity of biologics: analysis using nonlinear mixed-effects modeling.. Clinical Pharmacology and Therapeutics, American Society for Clinical Pharmacology and Therapeutics, 2012, 91 (2), pp.234-42. 〈10.1038/clpt.2011.216〉. 〈inserm-00660524〉

Partager

Métriques

Consultations de la notice

208

Téléchargements de fichiers

2624